| Brookhaven Nursing & Rehab | |
| 3405 West Mt Vernon, Springfield, Missouri 65802 | |
| (417) 874-9600 | |
| Name | Brookhaven Nursing & Rehab |
|---|---|
| Location | 3405 West Mt Vernon, Springfield, Missouri |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 90 |
| Occupancy Rate | 62.89% |
| Medicare ID (CCN) | 265835 |
| Legal Business Name | N & R Of Brookhaven Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1780906867 |
| Organization Name | CHRISTIAN HEALTH CARE OF SPRINGFIELD WEST PARK, INC |
| Doing Business As | BROOKHAVEN HEALTH CARE |
| Address | 3405 W Mount Vernon St, Springfield, MO 65802 |
| Phone Number | 417-874-9600 |
News Archive
Marburg virus is Ebola's deadly cousin. The virus is up to 90 percent lethal—and doctors are desperate for tools to fight it.
Encouraging new data from the wider distribution of anti-parasite drugs in pregnant women and very young children demonstrates that medicines commonly used to treat parasitic infections have much wider benefits than was previously thought.
Receiving an initial antibiotic prescription for a viral acute respiratory infection-the type of infection that doesn't respond to antibiotics-increases the likelihood that a patient or their spouse will seek care for future such infections and will receive subsequent antibiotic prescriptions, according to the findings of a study from Harvard Medical School and the Harvard T.H. Chan School of Public Health.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
Philips Respironics, a business of Royal Philips, will showcase its latest portfolio of sleep-disordered breathing and respiratory solutions September 26-29 at the European Respiratory Society (ERS) International Congress 2015 in Amsterdam. At booth 1.H_01, Hall 1, clinicians can experience the latest Philips sleep-disordered breathing solutions and new options for COPD management that connect and support the patient, clinician and caregiver to improve patient care and help patients to live active lives.
› Verified 5 days ago
| NPI Number | 1790879500 |
| Organization Name | CHRISTIAN HEALTH CARE OF SPRINGFIELD WEST PARK |
| Address | 3405 W Mount Vernon St, Springfield, MO 65802 |
| Phone Number | 417-891-9939 |
News Archive
Marburg virus is Ebola's deadly cousin. The virus is up to 90 percent lethal—and doctors are desperate for tools to fight it.
Encouraging new data from the wider distribution of anti-parasite drugs in pregnant women and very young children demonstrates that medicines commonly used to treat parasitic infections have much wider benefits than was previously thought.
Receiving an initial antibiotic prescription for a viral acute respiratory infection-the type of infection that doesn't respond to antibiotics-increases the likelihood that a patient or their spouse will seek care for future such infections and will receive subsequent antibiotic prescriptions, according to the findings of a study from Harvard Medical School and the Harvard T.H. Chan School of Public Health.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
Philips Respironics, a business of Royal Philips, will showcase its latest portfolio of sleep-disordered breathing and respiratory solutions September 26-29 at the European Respiratory Society (ERS) International Congress 2015 in Amsterdam. At booth 1.H_01, Hall 1, clinicians can experience the latest Philips sleep-disordered breathing solutions and new options for COPD management that connect and support the patient, clinician and caregiver to improve patient care and help patients to live active lives.
› Verified 5 days ago
| NPI Number | 1891091070 |
| Organization Name | REGIONAL CARE OF SPRINGFIELD WEST PARK, LLC |
| Doing Business As | BROOKHAVEN HEALTH AND REHABILITATION |
| Address | 3405 W Mount Vernon St, Springfield, MO 65802 |
| Phone Number | 417-874-9600 |
News Archive
Marburg virus is Ebola's deadly cousin. The virus is up to 90 percent lethal—and doctors are desperate for tools to fight it.
Encouraging new data from the wider distribution of anti-parasite drugs in pregnant women and very young children demonstrates that medicines commonly used to treat parasitic infections have much wider benefits than was previously thought.
Receiving an initial antibiotic prescription for a viral acute respiratory infection-the type of infection that doesn't respond to antibiotics-increases the likelihood that a patient or their spouse will seek care for future such infections and will receive subsequent antibiotic prescriptions, according to the findings of a study from Harvard Medical School and the Harvard T.H. Chan School of Public Health.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
Philips Respironics, a business of Royal Philips, will showcase its latest portfolio of sleep-disordered breathing and respiratory solutions September 26-29 at the European Respiratory Society (ERS) International Congress 2015 in Amsterdam. At booth 1.H_01, Hall 1, clinicians can experience the latest Philips sleep-disordered breathing solutions and new options for COPD management that connect and support the patient, clinician and caregiver to improve patient care and help patients to live active lives.
› Verified 5 days ago
| NPI Number | 1942607353 |
| Organization Name | N & R OF BROOKHAVEN LLC |
| Doing Business As | BROOKHAVEN NURSING & REHAB |
| Address | 3405 W Mount Vernon St, Springfield, MO 65802 |
| Phone Number | 417-874-9600 |
News Archive
Marburg virus is Ebola's deadly cousin. The virus is up to 90 percent lethal—and doctors are desperate for tools to fight it.
Encouraging new data from the wider distribution of anti-parasite drugs in pregnant women and very young children demonstrates that medicines commonly used to treat parasitic infections have much wider benefits than was previously thought.
Receiving an initial antibiotic prescription for a viral acute respiratory infection-the type of infection that doesn't respond to antibiotics-increases the likelihood that a patient or their spouse will seek care for future such infections and will receive subsequent antibiotic prescriptions, according to the findings of a study from Harvard Medical School and the Harvard T.H. Chan School of Public Health.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
Philips Respironics, a business of Royal Philips, will showcase its latest portfolio of sleep-disordered breathing and respiratory solutions September 26-29 at the European Respiratory Society (ERS) International Congress 2015 in Amsterdam. At booth 1.H_01, Hall 1, clinicians can experience the latest Philips sleep-disordered breathing solutions and new options for COPD management that connect and support the patient, clinician and caregiver to improve patient care and help patients to live active lives.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Marburg virus is Ebola's deadly cousin. The virus is up to 90 percent lethal—and doctors are desperate for tools to fight it.
Encouraging new data from the wider distribution of anti-parasite drugs in pregnant women and very young children demonstrates that medicines commonly used to treat parasitic infections have much wider benefits than was previously thought.
Receiving an initial antibiotic prescription for a viral acute respiratory infection-the type of infection that doesn't respond to antibiotics-increases the likelihood that a patient or their spouse will seek care for future such infections and will receive subsequent antibiotic prescriptions, according to the findings of a study from Harvard Medical School and the Harvard T.H. Chan School of Public Health.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
Philips Respironics, a business of Royal Philips, will showcase its latest portfolio of sleep-disordered breathing and respiratory solutions September 26-29 at the European Respiratory Society (ERS) International Congress 2015 in Amsterdam. At booth 1.H_01, Hall 1, clinicians can experience the latest Philips sleep-disordered breathing solutions and new options for COPD management that connect and support the patient, clinician and caregiver to improve patient care and help patients to live active lives.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.95 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.45 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 31.48 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.97 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 14.23 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 8.52 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.66 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 88.8 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 12.89 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 79.12 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 3.6 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 23.58 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 23.56 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 9.09 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.44 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 35.49 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 61.03 | 82.93 |
News Archive
Marburg virus is Ebola's deadly cousin. The virus is up to 90 percent lethal—and doctors are desperate for tools to fight it.
Encouraging new data from the wider distribution of anti-parasite drugs in pregnant women and very young children demonstrates that medicines commonly used to treat parasitic infections have much wider benefits than was previously thought.
Receiving an initial antibiotic prescription for a viral acute respiratory infection-the type of infection that doesn't respond to antibiotics-increases the likelihood that a patient or their spouse will seek care for future such infections and will receive subsequent antibiotic prescriptions, according to the findings of a study from Harvard Medical School and the Harvard T.H. Chan School of Public Health.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
Philips Respironics, a business of Royal Philips, will showcase its latest portfolio of sleep-disordered breathing and respiratory solutions September 26-29 at the European Respiratory Society (ERS) International Congress 2015 in Amsterdam. At booth 1.H_01, Hall 1, clinicians can experience the latest Philips sleep-disordered breathing solutions and new options for COPD management that connect and support the patient, clinician and caregiver to improve patient care and help patients to live active lives.
› Verified 5 days ago
Springfield Rehabilitation & Health Care Center Location: 2800 South Fort Avenue, Po Box 3438gs, Springfield, Missouri 65807 Phone: (417) 882-0035 | |
Wilson's Creek Nursing & Rehab Location: 3403 West Mt Vernon, Springfield, Missouri 65802 Phone: (417) 864-5600 | |
Spring Valley Health & Rehabilitation Center Location: 2915 South Fremont Ave, Springfield, Missouri 65804 Phone: (417) 883-4022 | |
Cox Medical Centers Meyer Orthopedic And Rehab Location: 3535 S National Ave, Springfield, Missouri 65807 Phone: (417) 269-9982 | |
Jordan Creek Nursing & Rehab Location: 910 South West Ave, Springfield, Missouri 65802 Phone: (417) 865-8741 | |
Glendale Gardens Nursing & Rehab Location: 3535 East Cherokee, Springfield, Missouri 65809 Phone: (417) 889-9955 |